Lenvatinib as a Therapeutic Option in Unresectable Metastatic Pheochromocytoma and Paragangliomas

Lauren Hassan Nelson; Harry Fuentes-Bayne; Jun Yin; Erik Asmus; Mabel Ryder; John C. Morris; Crystal R. Hilger; Keith C. Bible; Ashish V. Chintakuntlawar; Sarika N. Rao


J Endo Soc. 2022;6(5) 

In This Article


Our retrospective analysis demonstrated the efficacy of lenvatinib in mPPGL and shows that it may be a viable option to consider in salvage settings in mPPGL patients. Prospective multicenter studies with a larger sample size are needed to confirm the utility of lenvatinib in the treatment of mPPGL.